Thus, future studies should be geared to developing pharmacological approaches that simultaneously target both the cyst(e)ine–GSH–GPX4 node and the FSP1 system, allowing for efficient tumour cell eradication by triggering ferroptosis as a new anti-cancer paradigm. This evidence concerns the gene AIFM2 and neoplasm.